Clinical Trial Update: Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates autologous mesenchymal stem cell transplantation in people with relapsing-remitting, secondary progressive, or progressive-relapsin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis
• Progressive Relapsing Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Relapsing-Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis | Phase 1 | Status: COMPLETED